Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Core Insights - Stevanato Group will participate in the KeyBanc Capital Markets Virtual Healthcare Forum on March 17-18, 2026, presenting on March 17 from 9:45 to 10:20 a.m. ET [1] - The company is a leading global provider of drug containment, drug delivery, and diagnostic solutions, serving the pharmaceutical, biotechnology, and life sciences industries [1] - Stevanato Group reported a 7% revenue growth for fiscal year 2025, with a 9% increase on a constant currency basis, driven by record revenue from high-value solutions and expanded margins [1] Financial Performance - For Q4 2025, revenue increased by 5% (7% on a constant currency basis) to €346.5 million [1] - In Q3 2025, revenue rose by 9% (11% on a constant currency basis) to €303.2 million, with high-value solutions accounting for a record 49% of total revenue [1]